Medifast holders report 1.4% passive stake
Medifast, Inc. received an amended Schedule 13G filing showing that three affiliated Susquehanna entities collectively report beneficial ownership of 148,944 shares of Medifast common stock, representing 1.4% of the outstanding shares as of the event date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Medifast, Inc. received an amended Schedule 13G filing showing that three affiliated Susquehanna entities collectively report beneficial ownership of 148,944 shares of Medifast common stock, representing 1.4% of the outstanding shares as of the event date.
The reporting persons are G1 Execution Services, LLC, Susquehanna Fundamental Investments, LLC, and Susquehanna Securities, LLC. Susquehanna Securities, LLC’s position includes options to buy 139,300 shares. Medifast had 10,991,273 shares outstanding as of October 27, 2025, based on the company’s Form 10-Q.
The group certifies that the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Medifast, indicating a passive investment stance under the Schedule 13G framework.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Medifast (MED) is reported in this Schedule 13G/A?
Who are the reporting persons in the Medifast (MED) Schedule 13G/A filing?
Does the Medifast (MED) Schedule 13G/A indicate an activist or passive position?
What type of securities are covered in this Medifast (MED) Schedule 13G/A amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.